THE Department of Health (DoH) has welcomed the news that the CoronaVac vaccine of Chinese pharmaceutical company Sinovac Biotech has been given emergency clearance in China for children over three years old.
Sinovac Biotech chief executive Yin Weidong said in an interview on Chinese state media the country's regulators have approved the use of the vaccine based on phase one and phase two trials involving three to 17-year-olds.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.